Clotilde Allavena

4.7k total citations
112 papers, 1.9k citations indexed

About

Clotilde Allavena is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Clotilde Allavena has authored 112 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Infectious Diseases, 52 papers in Virology and 38 papers in Emergency Medicine. Recurrent topics in Clotilde Allavena's work include HIV/AIDS drug development and treatment (61 papers), HIV/AIDS Research and Interventions (54 papers) and HIV Research and Treatment (52 papers). Clotilde Allavena is often cited by papers focused on HIV/AIDS drug development and treatment (61 papers), HIV/AIDS Research and Interventions (54 papers) and HIV Research and Treatment (52 papers). Clotilde Allavena collaborates with scholars based in France, Canada and Martinique. Clotilde Allavena's co-authors include François Raffi, Lise Cuzin, André Cabié, Isabelle Poizot‐Martin, P. Dellamonica, Dominique Costagliola, Sophie Grabar, Claudine Duvivier, Véronique Reliquet and Michelle Bentata and has published in prestigious journals such as The Lancet, PLoS ONE and The Lancet Neurology.

In The Last Decade

Clotilde Allavena

104 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Clotilde Allavena 1.2k 850 601 474 135 112 1.9k
Núria Pérez‐Álvarez 1.0k 0.9× 853 1.0× 404 0.7× 803 1.7× 87 0.6× 80 1.9k
Vincenzo Colangeli 1.2k 1.0× 822 1.0× 436 0.7× 775 1.6× 188 1.4× 81 2.0k
Markus Bickel 1.1k 0.9× 657 0.8× 691 1.1× 638 1.3× 82 0.6× 73 1.9k
Mark S. Shaefer 1.5k 1.2× 1.1k 1.2× 419 0.7× 438 0.9× 194 1.4× 79 2.4k
Ighovwerha Ofotokun 929 0.8× 550 0.6× 336 0.6× 991 2.1× 100 0.7× 101 2.4k
Sasiwimol Ubolyam 865 0.7× 706 0.8× 463 0.8× 374 0.8× 92 0.7× 84 1.3k
Julio Collazos 727 0.6× 269 0.3× 423 0.7× 318 0.7× 167 1.2× 79 1.5k
Yang Han 1.2k 1.0× 487 0.6× 376 0.6× 273 0.6× 60 0.4× 104 1.8k
Ellen Tedaldi 1.2k 1.0× 701 0.8× 865 1.4× 893 1.9× 102 0.8× 52 2.2k
Julian Falutz 857 0.7× 679 0.8× 536 0.9× 1.3k 2.8× 94 0.7× 79 2.2k

Countries citing papers authored by Clotilde Allavena

Since Specialization
Citations

This map shows the geographic impact of Clotilde Allavena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clotilde Allavena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clotilde Allavena more than expected).

Fields of papers citing papers by Clotilde Allavena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clotilde Allavena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clotilde Allavena. The network helps show where Clotilde Allavena may publish in the future.

Co-authorship network of co-authors of Clotilde Allavena

This figure shows the co-authorship network connecting the top 25 collaborators of Clotilde Allavena. A scholar is included among the top collaborators of Clotilde Allavena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clotilde Allavena. Clotilde Allavena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hejblum, Gilles, Karine Amat, Sidonie Lambert-Niclot, et al.. (2025). Cost-effectiveness of a 4 days-a-week triple therapy in persons with HIV: an ancillary study of the QUATUOR trial. AIDS. 39(10). 1452–1461. 1 indexed citations
2.
Palich, Romain, Jade Ghosn, Karine Lacombe, et al.. (2025). Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study. Journal of Antimicrobial Chemotherapy. 81(1).
3.
Lê, Minh, Clotilde Allavena, Véronique Joly, et al.. (2025). Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057. Journal of Infection and Public Health. 18(11). 102946–102946.
4.
5.
6.
Allavena, Clotilde, et al.. (2023). The screening and management of sleep disturbances in people living with HIV: Delphi consensus. Journal of Sleep Research. 33(3). e14070–e14070.
7.
Hentzien, Maxime, Jaromil Frossard, Roger D. Kouyos, et al.. (2023). External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older. HIV Medicine. 25(1). 72–82.
8.
Cotte, Laurent, Clotilde Allavena, Thomas Huleux, et al.. (2022). High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort. PLoS ONE. 17(5). e0268670–e0268670. 7 indexed citations
9.
Gantner, Pierre, Clotilde Allavena, Claudine Duvivier, et al.. (2020). Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*. HIV Medicine. 21(7). 463–469. 4 indexed citations
10.
Gantner, Pierre, Laurent Cotte, Clotilde Allavena, et al.. (2019). Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection. PLoS ONE. 14(4). e0215464–e0215464. 18 indexed citations
11.
Cuzin, Lise, Cyrille Delpierre, Clotilde Allavena, et al.. (2019). Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort. PLoS ONE. 14(9). e0222067–e0222067. 13 indexed citations
12.
Cuzin, Lise, Pascal Puglièse, Clotilde Allavena, et al.. (2017). Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study. PLoS ONE. 12(12). e0187517–e0187517. 9 indexed citations
13.
Poizot‐Martin, Isabelle, Clotilde Allavena, Claudine Duvivier, et al.. (2016). CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART. PLoS ONE. 11(11). e0165774–e0165774. 21 indexed citations
14.
Cuzin, Lise, Pascal Puglièse, Clotilde Allavena, et al.. (2015). Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach. Medicine. 94(39). e1668–e1668. 2 indexed citations
15.
Bourgarit, A., Gabriel Baron, Guillaume Breton, et al.. (2015). Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country. Annals of the American Thoracic Society. 12(8). 1138–1145. 11 indexed citations
16.
Raffi, François, Abdel G. Babiker, Laura Richert, et al.. (2014). Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.. The Lancet Neurology. 384(9958). 1 indexed citations
17.
Bonnevialle, Nicolas, et al.. (2014). Outcomes from surgical treatment of middle-third clavicle fractures non-union in adults: A series of 21 cases. Orthopaedics & Traumatology Surgery & Research. 100(2). 175–180. 22 indexed citations
18.
Allavena, Clotilde, Stéphanie Delclaux, Nicolas Bonnevialle, et al.. (2014). Outcomes of bipolar radial head prosthesis to treat complex radial head fractures in 22 patients with a mean follow-up of 50 months. Orthopaedics & Traumatology Surgery & Research. 100(7). 703–709. 44 indexed citations
19.
Dailly, Éric, Clotilde Allavena, Régis Bouquié, et al.. (2012). Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients. AIDS Research and Human Retroviruses. 29(1). 42–46. 1 indexed citations
20.
Makinson, Alain, Sabrina Eymard‐Duvernay, Jean-Louis Pujol, et al.. (2011). Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer: Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort Study. Journal of Thoracic Oncology. 6(6). 1022–1029. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Núria Pérez‐Álvarez Breakdown of academic impact, for papers by Vincenzo Colangeli Breakdown of academic impact, for papers by Markus Bickel Breakdown of academic impact, for papers by Mark S. Shaefer Breakdown of academic impact, for papers by Ighovwerha Ofotokun Breakdown of academic impact, for papers by Sasiwimol Ubolyam Breakdown of academic impact, for papers by Julio Collazos Breakdown of academic impact, for papers by Yang Han Breakdown of academic impact, for papers by Ellen Tedaldi Breakdown of academic impact, for papers by Julian Falutz
Rankless by CCL
2026